Judith & Stewart Colton Center for Autoimmunity

The mission of NYU Langone’s Judith and Stewart Colton Center for Autoimmunity is to elucidate the initiating immunological events in autoimmunity and to develop new diagnostics and treatments for autoimmune diseases. To accomplish this goal, the Colton Center has established an extensive research effort among leading physicians and scientists with diverse expertise across the Medical Center and throughout the scientific community. Since its founding in 2013, the Colton Center has become a leading interdisciplinary component of NYU Langone’s strategy and a hub for autoimmune disease research.

The Judith and Stewart Colton Center for Autoimmunity emphasizes the importance of integrating novel fields of science and technology and collaboration between researchers and clinicians in order to make transformative discoveries designed to identify the environmental trigger and seminal immunological events that characterize the onset of autoimmune diseases.

The Center initially focused on using the basic science discoveries to develop and test novel strategies in the treatment and diagnosis of its three targeted diseases: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and antiphospholipid syndrome (APS). Synergistic translational research projects now include investigations into psoriatic arthritis, Behcet’s syndrome, inflammatory bowel disease, and multiple sclerosis.


In 2014, Judith and Stewart Colton made an extraordinary gift to establish the Colton Center for
Autoimmunity at NYU Langone.

The Center initially focused on using the basic science discoveries to develop and test novel strategies in the treatment and diagnosis of its three targeted diseases: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and antiphospholipid syndrome (APS). Synergistic translational research projects now include investigations into psoriatic arthritis, ankylosing spondylitis, and Behcet’s syndrome. Through the funding of new projects, future plans call for the expansion to other diseases such as diabetesinflammatory bowel disease, and multiple sclerosis.

Our Leadership

The center is led by Timothy Niewold, MD, the Director of the Judith and Stewart Colton Center for Autoimmunity and the Judith and Stewart Colton Professor of Medicine.  Dr. Niewold is internationally recognized for basic science and clinical research in the field of autoimmunity and genetics, and has published more than 150 papers in peer reviewed journals.  In recent NIH-funded studies, the Niewold Lab has examined the role of type I interferon in the development of lupus, as well as biomarkers of treatment response in rheumatoid arthritis patients. Read More >>